DDS(s) |
Drug-delivery system(s) |
BBB |
Blood–brain barrier |
CNS |
Central nervous system |
CMT, RMT and AMT |
Carrier-mediated, receptor-mediated and absorptive-mediated transcytosis |
P-gp |
P-glycoprotein |
WHO |
World Health Organization |
GBM |
Glioblastoma multiforme |
Tf, oTf and Lf |
serum-Transferrin, ovo-Transferrin and Lactoferrin |
TfR |
Transferrin receptor |
EPR |
Enhanced permeability and retention |
NP(s) |
Nanoparticle(s) |
AuNP(s) |
Gold nanoparticle(s) |
MNP(s) |
Magnetic nanoparticle(s) |
MRI |
Magnetic resonance imaging |
PM(s) |
Polymeric micelle(s) |
SNP(s) |
Polymeric solid nanoparticle(s) |
Apo-A1 and Apo-E |
Apolipoprotein A1 and Apolipoprotein E |
LbL assembly |
Layer-by-layer assembly |
LA and GA |
Lactic acid and Glycolic acid |
Abbreviated Chemicals: |
FTIC |
Fluorescein isothiocyanate |
IO |
Iron oxide |
PS-PAA |
Poly(styrene)-poly(acrylic acid) |
PEG-PLA |
Poly(ethylene)glycol-poly(lactic acid) |
PEG-DSPE |
Distearyl-sn-glycero-3-phosphoethanolamine-N-methoxy poly |
|
(ethylene glycol) |
PEG-PLA |
Poly(ethylene glycol)-poly(lactic acid) |
PEG-PLGA |
Poly(ethylene glycol)-poly(lactic-co-glycolic acid) |
DPX |
Dapoxetine |
PAMAM |
Polyamidoamine |
IL-13R2 |
Interleukin-13-receptor-2 |
EDC |
N-Ethyl-N-(3-dimethylaminopropyl)carbodiimide hydrochloride |
NHS |
N-hydroxysuccinimide |
PLGA |
Poly(lactic-co-glycolic acid) |
PEG |
Poly(ethylene(glycol |
BSA |
Bovine serum albumin |
FR
|
Folate receptor alpha |
Cur |
Curcumin |
g7 |
Gly-l-Phe-D-Thr-Gly-l-Phe-l-Leu-LSer(O--D-Glucose)-CONH
|
TMC |
Trimethylated chitosan |
PEP |
PLGA-PEG-PLGA |